Computational anatomy, computational biomodeling, computational genomics, computational neuroscience, computational pharmacology, computational evolutionary biology, cancer computational biology, and computational neuropsychiatry are the subtypes of computational biology.
The global computational biology market is estimated to account for US$ 12,601.1 Mn in terms of value by the end of 2027.
Global Computational Biology Market: Drivers
Increasing investment in computational biology is expected to propel growth of the global computational biology market over the forecast period. For instance, in May 2020, Insitro, the U.S.-based start-up raised US$ 143 million to boost machine learning-driven drug development.
Global Computational Biology Market: Opportunities
Adoption of cloud computing can address issues with high amount of data storage. Cloud storage solutions offer scalability and flexibility to match the volume of data. In addition, they allow large and potentially shared databases to be stored on the same infrastructure where a large-scale analysis is conducted. Cloud computing supports sharing of datasets, this can be achieved if one has a copy of a dataset on one’s local cluster.
Global Computational Biology Market: Restraints
Shortage of skilled resources is expected to hamper growth of the market. Currently there is a vast shortage of scientists adequately trained in computers and biology in the computational biology sector. There is a strong demand for scientists with unique strengths of medicine, biology, mathematics and physical sciences. Biologists with expertise in statistics, mathematical modeling, machine learning, artificial intelligence, software engineering, or database design are in demand.
The global computational biology market was valued at US$ 3,453.2 Mn in 2019 and is forecast to reach a value of US$ 12,601.1 Mn by 2027 at a CAGR of A.B% between 2020 and 2027. Increasing investment in computational biology is expected to propel growth of the global computational biology market over the forecast period.
Disease Modelling and Simulation Applications segment held dominant position in the global computational biology market in 2019, accounting for 60.0%% share in terms of value. Increasing research and development for new drug molecules is expected to drive the market growth.
Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in February 2020, Certara L.P. acquired a range of modeling and simulation technology assets for neurodegenerative diseases from In Silico Biosciences, Inc.
Major players in the market are also focused on conducting webinars to increase adoption of computational biology. For instance, in January 2020, Rosa & Co. LLC conducted a live webinar to demonstrate the importance of Pharmacometrics in vaccine discovery and development.
Global Computational Biology Market: Competitive Landscape
Major players operating in the global computational biology market include, Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
Global Computational Biology Market: Key Developments
May 2020: Genedata AG announced that Gritstone Oncology, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, has implemented Genedata Biologics, a purpose-built enterprise platform for biopharma R&D, within its R&D organization
April 2020: Certara L.P. launched version 19 of its Simcyp Population-based Simulator with new features to support safer and more efficient clinical studies, including models for testing drugs on pregnant women, enhanced drug formulation, and assessment of topical and transdermal drug products
Scope of the report